Quantitative HPLC-UV method for the determination of firocoxib from horse and dog plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 854, Issue 1-2, 2007, Pages 313-319

  Kvaternick, Valerie ^a   Malinski, Thomas ^a   Wortmann, Jill ^a   Fischer, James ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Coxib; Dog; Firocoxib; Horse; HPLC UV; Method validation; NSAID; Plasma

Indexed keywords

DOGS; FIROCOXIB; HORSE; METHOD VALIDATION;

CONDITION MONITORING; COPOLYMERS; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; STANDARDS;

BLOOD;

CYCLOOXYGENASE 2 INHIBITOR; FIROCOXIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG DETERMINATION; HORSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION;

4-BUTYROLACTONE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; HORSES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; SULFONES; THERAPEUTIC EQUIVALENCY;

CANIS FAMILIARIS; EQUIDAE;

EID: 34250884637     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.04.037     Document Type: Article

References (30)

1. Steele V., Hawke E.T., Viner J.L., and Lubet R.A. Mut. Res. 523-524 (2004) 137
2. Gilroy D.W., Lawrence T., Perretti M., and Rossi A.G. Nat. Rev. Drug Discov. 3 (2004) 401
3. Simmons D.L., Botting R.M., and Hla T. Pharmacol. Rev. 56 (2004) 387
4. Zhang F., Engebretson S.P., Morton R.S., et al. J. Am. Dent. Assoc. 134 (2003) 861
5. Xie W., Robertson D.L., and Simmons D.L. Drug Dev. Res. 25 (1992) 249
6. Kujubu D.A., Fletcher B.S., Varnum B.C., et al. J. Biol. Chem. 266 (1991) 12866
7. Stichtenoth D.O., and Frolich J.C. Drugs 63 (2003) 33
8. Schnitzer T.J., and Hochberg M.C. Cleve Clin. J. Med. 69 (2002) SI20
9. Reimer M., Johnston S., et al. J. Vet. Intern. Med. 13 (1999) 472
10. Forsyth S.F., Guilford W.G., and Lawoko C.R.O. N. Z. Vet. J. 44 (1996) 179
11. Hawkey C.J. Gut 50 (2002) 25
12. Garnet W.R. Pharmacotherapy 21 (2001) 1223
13. Hinz B., and Brun K. J. Pharmacol. Exp. Ther. 300 (2002) 367
14. McCann M.E., Andersen D.R., et al. Am. J. Vet. Res. 65 (2004) 503
15. Tacconelli S., Capone M., et al. Curr. Med. Res. Opin. 18 (2002) 503
16. Patrignani P., Tacconelli S., Sciulli M., and Capone M. Brain Res. Rev. 48 (2005) 352
17. Erk N., and Altunitas T. Pharmazie 59 (2004) 453
18. Aminni M., PirAli Hamedani M., Vosooghi M., et al. Anal. Bioanl. Chem. 382 (2005) 1265
19. Shehata M.A., Ashour A., Hassan N.Y., et al. Anal. Chim. Acta 519 (2004) 23
20. Sane R.T., Menon S., Deshpande A.Y., and Jain A. Chromatographia 61 (2005) 137
21. Nageswara Rao R., Meena S., and Raghuram Rao A. J. Pharm. Biomed. Anal. 39 (2005) 349
22. Zarghi A., Shafaati A., Foroutan S.M., and Khoddam A. J. Chromatogr. B 835 (2006) 100
23. Ramakrishna N.V.S., Wishwottam K.N., Wishu S., and Koteshwara M. J. Chromatogr. B 816 (2005) 215
24. Nageswara Rao R., Meena S., Nagaraju D., and Raghu Ram Rao A. Biomed. Chromatogr. 19 (2005) 362
25. FDA Code of Federal Regulations Title 21 Part 58.
26. FDA Guidance for Industry 145 Bioanalytical Method Validation May 2001.
27. Kvaternick V., Pollmeier M., Hanson P.D., and Fischer J. J. Vet. Pharmacol. Ther. 30 (2007) 208
28. Merial Ltd., unpublished data.
29. Cho H.-Y., Park C.-H., and Lee Y.-B. J. Chromatogr. B 835 (2006) 27
30. Haefelfinger P. J. Chromatogr. 218 (1981) 73